See more : Denison Mines Corp. (DNN) Income Statement Analysis – Financial Results
Complete financial analysis of Spectral AI, Inc. (MDAI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Spectral AI, Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Cardinal Health, Inc. (CAH) Income Statement Analysis – Financial Results
- Advanced Info Service Public Company Limited (ADVANC-R.BK) Income Statement Analysis – Financial Results
- Moriya Transportation Engineering and Manufacturing Co.,Ltd. (6226.T) Income Statement Analysis – Financial Results
- Wearable Devices Ltd. (WLDSW) Income Statement Analysis – Financial Results
- Netflix, Inc. (NFC.DE) Income Statement Analysis – Financial Results
Spectral AI, Inc. (MDAI)
About Spectral AI, Inc.
Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Metric | 2023 | 2022 | 2021 |
---|---|---|---|
Revenue | 18.06M | 25.37M | 15.24M |
Cost of Revenue | 10.18M | 14.53M | 8.19M |
Gross Profit | 7.88M | 10.84M | 7.05M |
Gross Profit Ratio | 43.64% | 42.72% | 46.28% |
Research & Development | 0.00 | 0.00 | 0.00 |
General & Administrative | 20.86M | 13.48M | 11.23M |
Selling & Marketing | 0.00 | 0.00 | 0.00 |
SG&A | 20.86M | 13.48M | 11.23M |
Other Expenses | 0.00 | 49.00K | 0.00 |
Operating Expenses | 20.86M | 13.48M | 11.23M |
Cost & Expenses | 31.04M | 28.02M | 19.42M |
Interest Income | 172.00K | 21.00K | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 722.00K | 568.00K | 1.00K |
EBITDA | -12.26M | -2.08M | -4.18M |
EBITDA Ratio | -67.91% | -7.42% | -28.14% |
Operating Income | -12.98M | -2.65M | -4.18M |
Operating Income Ratio | -71.91% | -10.43% | -27.42% |
Total Other Income/Expenses | -7.86M | -159.00K | 93.00K |
Income Before Tax | -20.84M | -2.81M | -4.09M |
Income Before Tax Ratio | -115.44% | -11.06% | -26.81% |
Income Tax Expense | 11.00K | 106.00K | -98.00K |
Net Income | -20.85M | -2.91M | -3.99M |
Net Income Ratio | -115.50% | -11.48% | -26.17% |
EPS | -1.48 | -0.16 | -0.22 |
EPS Diluted | -1.48 | -0.16 | -0.22 |
Weighted Avg Shares Out | 14.09M | 17.88M | 17.88M |
Weighted Avg Shares Out (Dil) | 14.09M | 17.88M | 17.88M |
AI in Wound Care Market Industry Research Report 2024-2035 Featuring Key Players - eKare, healthy.io, Kronikare, Intellicure, Perceptive Solutions, Spectral AI, Swift Medical, Wound Pros Among Others
Spectral AI founder returns as board chairman
Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
Spectral AI completes proof-of-concept for wound measurement technology
Spectral AI Completes Proof of Concept for Wound Measurement Technology
Spectral AI reaches key milestone in US burn study, expands clinical trial sites
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
Spectral AI preparing to seek FDA approval of DeepView burn assessment device
Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication
Spectral AI highlights potential of its wound analysis device to bridge burn care gaps
Source: https://incomestatements.info
Category: Stock Reports